These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
64. Langerhans cell histiocytosis and Erdheim-Chester disease, both with cutaneous presentations, and papillary thyroid carcinoma all harboring the BRAF(V600E) mutation. Johnson WT; Patel P; Hernandez A; Grandinetti LM; Huen AC; Marks S; Ho J; Monaco SE; Jaffe R; Picarsic J J Cutan Pathol; 2016 Mar; 43(3):270-5. PubMed ID: 26454140 [TBL] [Abstract][Full Text] [Related]
65. Biological and therapeutic implications of the BRAF pathway in histiocytic disorders. Arceci RJ Am Soc Clin Oncol Educ Book; 2014; ():e441-5. PubMed ID: 24857137 [TBL] [Abstract][Full Text] [Related]
66. Coexistence of intracranial Langerhans cell histiocytosis and Erdheim-Chester disease in a pediatric patient: a case report. Kim S; Lee M; Shin HJ; Lee J; Suh YL Childs Nerv Syst; 2016 May; 32(5):893-6. PubMed ID: 26466952 [TBL] [Abstract][Full Text] [Related]
67. Effective BRAF inhibitor vemurafenib therapy in a 2-year-old patient with sequentially diagnosed Langerhans cell histiocytosis and Erdheim-Chester disease. Váradi Z; Bánusz R; Csomor J; Kállay K; Varga E; Kertész G; Csóka M Onco Targets Ther; 2017; 10():521-526. PubMed ID: 28182116 [TBL] [Abstract][Full Text] [Related]
68. Erdheim-Chester disease involving the breast--a rare but important differential diagnosis. Guo S; Yan Q; Rohr J; Wang Y; Fan L; Wang Z Hum Pathol; 2015 Jan; 46(1):159-64. PubMed ID: 25454479 [TBL] [Abstract][Full Text] [Related]
69. Excellent response of intramedullary Erdheim-Chester disease to vemurafenib: a case report. Tzoulis C; Schwarzlmüller T; Gjerde IO; Søfteland E; Neckelmann G; Biermann M; Haroche J; Straume O; Vintermyr OK BMC Res Notes; 2015 Apr; 8():171. PubMed ID: 25926131 [TBL] [Abstract][Full Text] [Related]
70. Acute Pancreatitis From Treatment With BRAF Inhibitors in Erdheim-Chester Disease: A Report From 2 Tertiary Referral Centers. Ruan GJ; Goyal G; Shah MV; Cohen-Aubart F; Amoura Z; Straetmans N; Benameur N; Haroche J; Go RS; Pancreas; 2021 Jan; 50(1):e6-e8. PubMed ID: 33370037 [No Abstract] [Full Text] [Related]
71. Central nervous system involvement in Erdheim-Chester disease: An observational cohort study. Cohen Aubart F; Idbaih A; Galanaud D; Law-Ye B; Emile JF; Charlotte F; Donadieu J; Maksud P; Seilhean D; Amoura Z; Hoang-Xuan K; Haroche J Neurology; 2020 Nov; 95(20):e2746-e2754. PubMed ID: 32887776 [TBL] [Abstract][Full Text] [Related]
72. Erdheim-Chester disease of brain parenchyma without any systemic involvement: A case report and review of literature. Aktan Suzgun M; Everest E; Kucukyurt S; Tutuncu M; Uygunoglu U; Eskazan AE; Ture U; Budka H; Sav A; Siva A Neuropathology; 2024 Feb; 44(1):59-67. PubMed ID: 37357975 [TBL] [Abstract][Full Text] [Related]
73. [Erdheim-Chester disease with cardiac involvement. Case report]. Latyshev VD; Mershina EА; Kostina IE; Sinitsyn VЕ; Lukina EA Ter Arkh; 2022 Aug; 94(7):897-902. PubMed ID: 36286949 [TBL] [Abstract][Full Text] [Related]
74. Clinical and Radiologic Responses to Cladribine for the Treatment of Erdheim-Chester Disease. Goyal G; Shah MV; Call TG; Litzow MR; Hogan WJ; Go RS JAMA Oncol; 2017 Sep; 3(9):1253-1256. PubMed ID: 28253394 [TBL] [Abstract][Full Text] [Related]
76. [Erdheim-Chester disease initially discovered at extraskeletal locations: a clinicopathological analysis of four cases]. Niu ZR; Wu JH; Tan YJ; Luo DJ; Xu X Zhonghua Bing Li Xue Za Zhi; 2024 Apr; 53(4):364-369. PubMed ID: 38556820 [No Abstract] [Full Text] [Related]
77. Cardiovascular manifestations of Erdheim-Chester disease: A narrative review with two cases. Wong A; Sharma A; Ramcharitar R Vasc Med; 2024 Jun; 29(3):313-319. PubMed ID: 38469821 [TBL] [Abstract][Full Text] [Related]
78. BRAF V600E mutations are not an oncogenic driver of solitary xanthogranuloma and reticulohistiocytoma: Testing may be useful in screening for Erdheim-Chester disease. Hoyt BS; Yan S; Linos KD; Momtahen S; Sriharan A; Tran TN; Tsongalis GJ; O'Meara RR; Green DC; LeBlanc RE Exp Mol Pathol; 2019 Dec; 111():104320. PubMed ID: 31639332 [TBL] [Abstract][Full Text] [Related]
79. Erdheim-Chester disease as complex clinical presentation and diagnosis: A case report and concise review of literature. Gagliardo CM; Giammanco A; Vaglio A; Pegoraro F; Cefalù AB; Averna M; Noto D Medicine (Baltimore); 2024 Apr; 103(17):e37870. PubMed ID: 38669404 [TBL] [Abstract][Full Text] [Related]
80. 18F-fluoride PET/CT aspect of an unusual case of Erdheim-Chester disease with histologic features of Langerhans cell histiocytosis. Caoduro C; Ungureanu CM; Rudenko B; Angoue O; Blagosklonov O; Paycha F; Boulahdour H Clin Nucl Med; 2013 Jul; 38(7):541-2. PubMed ID: 23603579 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]